[Measurements of survival in the evaluation of a treatment. The cardiologist and the large clinical trials of coronary thrombolysis].
Since late eighties, large clinical trials on thrombolytic therapy have introduced in cardiology literature the use of survival measures in order to assess the consequences of treatment. In this article a systematic review of the more frequently adopted measures is presented, together with the proposal of other measures, more useful for the clinician.